2022
Benefits of weight loss of 10% or more in patients with overweight or obesity: A review
Tahrani AA, Morton J. Benefits of weight loss of 10% or more in patients with overweight or obesity: A review. Obesity 2022, 30: 802-840. PMID: 35333446, DOI: 10.1002/oby.23371.Peer-Reviewed Original ResearchMeSH KeywordsAnti-Obesity AgentsDiabetes Mellitus, Type 2HumansObesityOverweightPhentermineQuality of LifeTopiramateWeight LossConceptsObesity-related complicationsModest weight lossWeight lossBariatric surgeryLarge weight lossReduced cancer riskWeight-related complicationsCardiovascular risk factorsHealth-related qualityWeight management programType 2 diabetesGreater weight lossMain treatment targetsCost-effective interventionLifestyle modificationLifestyle interventionSevere obesityKnee osteoarthritisSleep apneaRisk factorsCancer riskGlucose metabolismPatientsOverweightTreatment targets
2021
Bariatric-Metabolic Surgery Utilisation in Patients With and Without Diabetes: Data from the IFSO Global Registry 2015–2018
Welbourn R, Hollyman M, Kinsman R, Dixon J, Cohen R, Morton J, Ghaferi A, Higa K, Ottosson J, Pattou F, Al-Sabah S, Anvari M, Himpens J, Liem R, Våge V, Walton P, Brown W, Kow L. Bariatric-Metabolic Surgery Utilisation in Patients With and Without Diabetes: Data from the IFSO Global Registry 2015–2018. Obesity Surgery 2021, 31: 2391-2400. PMID: 33638756, PMCID: PMC8113173, DOI: 10.1007/s11695-021-05280-6.Peer-Reviewed Original ResearchMeSH KeywordsAgedBariatric SurgeryCross-Sectional StudiesDiabetes Mellitus, Type 2FemaleGastrectomyGastric BypassHumansMaleMiddle AgedObesity, MorbidRegistriesTreatment OutcomeConceptsBody mass indexType 2 diabetes mellitusMethodsCross-sectional analysisRates of T2DMBariatric-metabolic surgeryHigh rateGastric bypassPrimary surgerySleeve gastrectomyDiabetes mellitusMass indexGlobal RegistryBaseline ageNational registryInclusion criteriaT2DMType of operationPatientsOlder menWomenSurgeryRegistryMenHigher proportionCommon operation
2020
Safety and Efficacy of Bariatric and Metabolic Surgery
Ghiassi S, Morton JM. Safety and Efficacy of Bariatric and Metabolic Surgery. Current Obesity Reports 2020, 9: 159-164. PMID: 32253662, DOI: 10.1007/s13679-020-00377-y.Peer-Reviewed Original ResearchConceptsDurable weight lossBariatric surgeryRisk/benefit ratioWeight lossRisk of complicationsCurrent medical treatmentRisk of mortalityObesity-related diseasesReviewBariatric surgeryBariatric proceduresCause morbidityMetabolic surgeryObesity comorbiditiesMedical managementRelated comorbiditiesSafety profileCardiovascular diseaseGlobal prevalenceMedical treatmentSurgeryBenefit ratioMortalityComorbiditiesMorbidityDurable method
2019
Using Machine Learning Applied to Real-World Healthcare Data for Predictive Analytics: An Applied Example in Bariatric Surgery
Johnston SS, Morton JM, Kalsekar I, Ammann EM, Hsiao CW, Reps J. Using Machine Learning Applied to Real-World Healthcare Data for Predictive Analytics: An Applied Example in Bariatric Surgery. Value In Health 2019, 22: 580-586. PMID: 31104738, DOI: 10.1016/j.jval.2019.01.011.Peer-Reviewed Original ResearchMeSH KeywordsBariatric SurgeryDatabases, FactualDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsInsurance Claim ReviewMachine LearningMaleMiddle AgedConceptsLarge US healthcare claims databasesLaparoscopic metabolic surgeryHealthcare claims databasesType 2 diabetesStudy inclusion criteriaLogistic regression modelsDays postindexMedication cessationBariatric surgeryMetabolic surgeryT2D diagnosisCessation ratesPatient selectionMedication treatmentClaims databaseInclusion criteriaTreatment responseDiscriminative accuracyPatientsExternal validationSurgeryRegression modelsHealthcare dataTreatmentUseful predictive modelsThe Impact of Ethnicity on Metabolic Outcomes after Bariatric Surgery
Valencia A, Garcia LC, Morton J. The Impact of Ethnicity on Metabolic Outcomes after Bariatric Surgery. Journal Of Surgical Research 2019, 236: 345-351. PMID: 30694776, DOI: 10.1016/j.jss.2018.09.061.Peer-Reviewed Original ResearchConceptsBody mass indexBariatric surgeryMetabolic outcomesDiabetic outcomesOral medicationsBlack patientsMass indexAsian patientsLaparoscopic sleeve gastrectomy procedureType II diabetes mellitusSignificant metabolic improvementSimilar metabolic outcomesSleeve gastrectomy procedureMajority of patientsAsian patient populationSingle academic institutionEthnic minority patientsNon-Hispanic whitesDiabetes remissionDiabetes resolutionGastric bypassLaparoscopic RouxPostoperative visitDiabetes mellitusMetabolic improvement
2016
Bariatric Surgery Overview of Procedures and Outcomes
Azagury DE, Morton JM. Bariatric Surgery Overview of Procedures and Outcomes. Endocrinology And Metabolism Clinics Of North America 2016, 45: 647-656. PMID: 27519136, DOI: 10.1016/j.ecl.2016.04.013.Peer-Reviewed Original ResearchMeSH KeywordsBariatric SurgeryDiabetes Mellitus, Type 2Gastric BypassHumansLaparoscopyObesity, MorbidObservational Studies as TopicRandomized Controlled Trials as TopicWeight LossConceptsBariatric surgeryType 2 diabetic patientsWeight loss therapyMultiple randomized control trialsDiabetes-related mortalityAdvent of laparoscopyRandomized control trialGastric bypassDiabetic patientsLoss therapyObservational studyControl trialMortality ratePatientsSurgeryRemissionBMIDiabetesLaparoscopyBypassTherapyMortalityTrialsEffect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study
Morton JM, Shah SN, Wolfe BM, Apovian CM, Miller CJ, Tweden KS, Billington CJ, Shikora SA. Effect of Vagal Nerve Blockade on Moderate Obesity with an Obesity-Related Comorbid Condition: the ReCharge Study. Obesity Surgery 2016, 26: 983-989. PMID: 27048437, PMCID: PMC4831996, DOI: 10.1007/s11695-016-2143-y.Peer-Reviewed Original ResearchMeSH KeywordsAdultBody Mass IndexDiabetes Mellitus, Type 2Double-Blind MethodDyslipidemiasFemaleHumansHypertensionMaleMiddle AgedNerve BlockObesityTreatment OutcomeVagus NerveWeight LossConceptsObesity-related comorbid conditionsBody mass indexModerate obesityComorbid conditionsPercentage excess weight lossWeight lossImplant site painVagal nerve blockadeCommon adverse eventsExcess weight lossObesity-related comorbiditiesWeight management counselingType 2 diabetesGreater weight lossSite painAdverse eventsBlockade therapyPrespecified subgroupsSevere obesitySham deviceMass indexNerve blockadeSleep apneaSafety profileClinical trials
2013
Metabolic Surgery for Type 2 Diabetes in BMI <35: A Surgeon’s View
Scharf K, Morton J. Metabolic Surgery for Type 2 Diabetes in BMI <35: A Surgeon’s View. Obesity Surgery 2013, 24: 144-145. PMID: 24155110, DOI: 10.1007/s11695-013-1098-5.Peer-Reviewed Original ResearchBariatric SurgeryBody Mass IndexDiabetes Mellitus, Type 2FemaleHumansMaleObesity, MorbidPatient SelectionSevere worsening of diabetic retinopathy following bariatric surgery.
Silva RA, Morton JM, Moshfeghi DM. Severe worsening of diabetic retinopathy following bariatric surgery. Ophthalmic Surgery Lasers And Imaging Retina 2013, 44 Online: e11-4. PMID: 24131131, DOI: 10.3928/23258160-20131009-01.Peer-Reviewed Original ResearchMeSH KeywordsBariatric SurgeryDiabetes Mellitus, Type 2Diabetic RetinopathyFemaleHumansMiddle AgedObesity, MorbidConceptsDiabetic retinopathyBariatric surgeryStable diabetic retinopathyGastric bypass surgeryHemoglobin A1c levelsMonths of surgeryUseful visual acuityShort-term worseningLaparoscopic RouxBypass surgeryA1c levelsDiabetes mellitusGlycemic controlLeft eyeRetinal evaluationVisual acuityRight eyeRapid worseningVisual functionLong-term reductionSevere worseningRetinopathySurgeryWorseningPatients
2008
Bariatric Surgery in Patients With Morbid Obesity and Type 2 Diabetes
Schernthaner G, Morton JM. Bariatric Surgery in Patients With Morbid Obesity and Type 2 Diabetes. Diabetes Care 2008, 31: s297-s302. PMID: 18227500, DOI: 10.2337/dc08-s270.Peer-Reviewed Original Research